Skip to main content
. 2017 Jun 2;35(2):192–200. doi: 10.1080/02813432.2017.1333305

Table 3.

QIs focusing on the choice of antibiotics.

QIs as a ratio (nominator: denominator) Acceptable range (%) Median, range 1–9
Patients with acute pharyngotonsillitis
 Number of patients treated with penicillin V: number of patients treated with antibiotics 90–100 9*
 Number of patients with known penicillin allergy treated with macrolides: number of patients treated with macrolides 90–100 9*
 Number of patients without known penicillin allergy treated with macrolides: number of patients treated with macrolides 0–10 9*
Patients with acute otitis media
 Number of patients treated with penicillin V: number of patients treated with antibiotics 90–100 9*
 Number of patients treated with amoxicillin ± clavulanic acid: number of patients treated with antibiotics 0–20 9*
 Number of patients with known penicillin allergy treated with macrolides: number of patients treated with macrolides 90–100 9*
 Number of patients without known penicillin allergy treated with macrolides: number of patients treated with macrolides 0–10 9*
Patients with acute rhinosinusitis
 Number of patients treated with penicillin V: number of patients treated with antibiotics 90–100 9*
 Number of patients treated with amoxicillin ± clavulanic acid: number of patients treated with antibiotics 0–20 9
 Number of patients with known penicillin allergy treated with macrolides: number of patients treated with macrolides 90–100 9*
 Number of patients without known penicillin allergy treated with macrolides: number of patients treated with macrolides 0–10 9*
Patients with acute bronchitis
 Number of patients treated with penicillin V: number of patients treated with antibiotics 90–100 9*
 Number of patients treated with amoxicillin ± clavulanic acid: number of patients treated with antibiotics 0–10 9*
 Number of patients with known penicillin allergy treated with macrolides: number of patients treated with macrolides 90–100 9*
 Number of patients without known penicillin allergy treated with macrolides: number of patients treated with macrolides 0–10 9*
Patients with pneumonia
 Number of patients treated with penicillin V: number of patients treated with antibiotics 80–100 9*
 Number of patients with known penicillin allergy treated with macrolides: number of patients treated with macrolides 90–100 9*
 Number of patients without known penicillin allergy treated with macrolides: number of patients treated with macrolides 0–10a 9*
Patients with acute exacerbation of COPD
 Number of patients treated with amoxicillin ± clavulanic acid: number of patients treated with antibiotics 80–100 8
 Number of patients without known penicillin allergy treated with quinolones: number of patients treated with quinolones 0–10 9*
Patients with acute RTI
 Number of patients without known penicillin allergy treated with macrolides: number of patients treated with macrolides 0–10 9*
*

Consensus of appropriateness.

a

This standard cannot be used during a mycoplasma epidemic.